Galderma Group AG (GDERF)
185.50
-5.68
(-2.97%)
USD |
OTCM |
Sep 15, 16:00
Galderma Group Price : 185.50 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 181.23 | 185.50 | 181.23 | 185.50 | 110.00 |
| Sep 14, 2026 | 184.54 | 199.05 | 184.52 | 191.18 | 55.00 |
| Sep 11, 2026 | 198.85 | 198.85 | 183.88 | 183.88 | 23.00 |
| Sep 10, 2026 | 192.05 | 192.05 | 187.00 | 187.00 | 45.00 |
| Sep 09, 2026 | 190.37 | 202.63 | 190.37 | 202.63 | 48.00 |
| Sep 08, 2026 | 211.30 | 211.30 | 194.09 | 211.02 | 15.00 |
| Sep 04, 2026 | 198.00 | 198.00 | 198.00 | 198.00 | 11.00 |
| Sep 03, 2026 | 211.85 | 211.85 | 197.75 | 198.00 | 8.000 |
| Sep 02, 2026 | 210.95 | 211.70 | 202.00 | 211.70 | 66.00 |
| Sep 01, 2026 | 207.00 | 214.25 | 196.50 | 207.00 | 189.00 |
| Aug 31, 2026 | 216.45 | 216.45 | 207.75 | 207.75 | 16.00 |
| Aug 28, 2026 | 223.20 | 223.20 | 206.50 | 206.50 | 39.00 |
| Aug 27, 2026 | 205.15 | 206.01 | 205.15 | 206.01 | 54.00 |
| Aug 26, 2026 | 214.88 | 223.30 | 214.88 | 223.30 | 37.00 |
| Aug 25, 2026 | 219.05 | 219.80 | 212.71 | 219.80 | 8.000 |
| Aug 24, 2026 | 213.65 | 221.55 | 205.75 | 205.75 | 28.00 |
| Aug 21, 2026 | 221.55 | 222.30 | 221.55 | 222.30 | 10.00 |
| Aug 20, 2026 | 205.75 | 205.75 | 205.01 | 205.01 | 18.00 |
| Aug 19, 2026 | 218.05 | 218.80 | 211.50 | 218.80 | 19.00 |
| Aug 18, 2026 | 198.60 | 212.15 | 198.60 | 212.15 | 7.000 |
| Aug 17, 2026 | 205.05 | 218.05 | 205.05 | 205.05 | 39.00 |
| Aug 14, 2026 | 221.65 | 222.40 | 221.65 | 222.40 | 22.00 |
| Aug 13, 2026 | 210.70 | 210.70 | 210.70 | 210.70 | 5640.00 |
| Aug 12, 2026 | 210.70 | 210.70 | 210.70 | 210.70 | 1.000 |
| Aug 11, 2026 | 228.55 | 228.55 | 228.55 | 228.55 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 138.62 |
| Roche Holding AG | 54.94 |
| Addex Therapeutics Ltd. | 3.26 |
| Oculis Holding AG | 10.07 |
| Sandoz Group AG | 80.60 |
Price Related Metrics
| PE Ratio | 50.66 |
| PS Ratio | 7.420 |
| Price to Free Cash Flow | 41.21 |
| Earnings Yield | 1.97% |
| Market Cap | 43.26B |
| Operating PE Ratio | 40.04 |
| Normalized PE Ratio | 47.29 |